Russia has reached the world vaccine race. According to a new peer-reviewed study published on Tuesday, the country’s two-shot Sputnik V vaccine has been shown to be 91.6% effective against symptomatic COVID-19 and is completely effective against severe cases. There had been a lot of skepticism around Russia’s shooting, which was approved by Russian authorities in August, due to its incredibly rapid development and the lack of reliable published data from the trials. But the findings, which emerged as a result of a large-scale clinical trial published in the British medical journal The Lancet, it will help you eliminate this doubt. The efficacy rate is similar to Western vaccines developed by Moderna and Pfizer / BioNTech. Sputnik V has already been delivered to more than two million people worldwide, including in Argentina, Serbia and Algeria. It does not require special refrigeration by freezing.
Read it on Wall Street Journal